Promising trial results support marketing authorisation application

Successful phase 1 study highlights potential of roginolisib

Promising results set stage for European marketing authorization

New cell therapy shows potential in treating advanced blood disorder

New findings presented at international SCWD conference

Trial results lead to new treatment option for lung cancer

promising pre-clinical data on preventing cytokine release syndrome

Phase 3 trial indicates significant efficacy and safety for children and adolescents

New antibody therapy shows promise in managing condition

Versant Ventures leads investment round to advance drug